Evidence map›Paper›PMID 24505621›Full record

ArticleBrain research2014

Excitotoxic glutamate insults block autophagic flux in hippocampal neurons.

Jacqueline R Kulbe, Jean M Mulcahy Levy, Steven J Coultrap, Andrew Thorburn, K Ulrich Bayer

Abstract read
In one paragraph

Article in Brain research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. The P2X7 Receptor in Osteoarthritis.Frontiers in cell and developmental biology · 2021
    Review
  11. Article
  12. Article
  13. mTOR-Related Cell-Clearing Systems in Epileptic Seizures, an Update.International journal of molecular sciences · 2020
    Review
  14. Review
  15. Cell Clearing Systems Bridging Neuro-Immunity and Synaptic Plasticity.International journal of molecular sciences · 2019
    Review
  16. Rapamycin in ischemic stroke: Old drug, new tricks?Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2019
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jacqueline R Kulbe
Jean M Mulcahy Levy
Steven J Coultrap
Andrew Thorburn
K Ulrich Bayer

Funding

ZEBRAFISH TRANSGENIC CORE - ROCKY MOUNTAIN NEUROLOGICAL DISORDERS CORE CENTERP30NS048154 · NINDS · UNIVERSITY OF COLORADO DENVER · PI RIBERA, ANGELES BADELL · 2004 to 2020
$10.1M
Role of autophagy in tumor cell deathR01CA150925 · NCI · UNIVERSITY OF COLORADO DENVER · PI DEGREGORI, JAMES V · 2010 to 2024
$5.5M
Training in Basic and Translational Child Health ResearchK12HD068372 · NICHD · UNIVERSITY OF COLORADO DENVER · PI DANIELS, STEPHEN R · 2011 to 2020
$3.7M
FADD Signaling in Cancer CellsR01CA111421 · NCI · UNIVERSITY OF COLORADO DENVER · PI THORBURN, ANDREW M · 2005 to 2014
$2.8M
CaMKII in global cerebral ischemiaR01NS080851 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BAYER, K. ULRICH, HERSON, PACO S · 2013 to 2017
$2.1M
Structural and Catalytic Functions of CaMKII in NeuronsR01NS052644 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BAYER, K. ULRICH · 2007 to 2011
$1.7M
NCI NIH HHS R01 CA111421NCI NIH HHS R01CA111421NCI NIH HHS R01 CA150925NCI NIH HHS R01CA150925NICHD NIH HHS K12 HD068372NICHD NIH HHS K12HD068372NINDS NIH HHS P30NS04154NINDS NIH HHS P30 NS048154NINDS NIH HHS R01 NS052644NINDS NIH HHS R01 NS080851NINDS NIH HHS R01NS080851
6 · The paper itself

Abstract

Excitotoxic insults such as cerebral ischemia are thought to enhance neuronal autophagy, which is then thought to promote neuronal cell death. Excitotoxic insults indeed increase autophagy markers. Notably, however, autophagy markers can be increased either by autophagy induction (as this enhances their production) or by late-stage autophagy inhibition (as this prevents their degradation during autophagic flux). By comparing each condition with and without protease inhibitors that prevent autophagic degradation of the autophagy markers, the results of this study show that excitotoxic glutamate increases autophagy markers by a late-stage block of autophagy. Initially, this study set out to test if the CaMKII inhibitor tatCN21 mediates its post-insult neuroprotection by regulating autophagy. While tatCN21 partially inhibited basal autophagy in hippocampal neurons, it had no effects on the already blocked autophagy after excitotoxic glutamate insults, indicating that autophagy inhibition is not its neuroprotective mechanism. Additionally, while the autophagy inhibitor chloroquine had no effect, significant neuroprotection was seen instead with two drugs that enhance autophagy induction by different mechanisms, rapamycin (mTOR-dependent) and trehalose (mTOR-independent). This suggests that therapeutic approaches should seek to enhance rather than inhibit autophagy, not only in neurodegenerative diseases (where such approach is widely accepted) but also after acute excitotoxic insults. Together, these findings significantly reshape the current view on the mutual cross-regulation of autophagy and excitotoxicity.

Indexed as

AnimalsAnimals, NewbornAutophagyCells, CulturedExcitatory Amino Acid AgonistsGlutamic AcidHeat-Shock ProteinsHippocampusLeucineMicrotubule-Associated ProteinsNeuronsPepstatinsProtease InhibitorsRatsSequestosome-1 ProteinStatistics, NonparametricaloxistatinAnxa3 protein, ratExcitatory Amino Acid AgonistsGlutamic AcidHeat-Shock ProteinsLeucineMicrotubule-Associated ProteinspepstatinPepstatinsProtease InhibitorsSequestosome-1 ProteinSqstm1 protein, rat

Identifiers

PMID24505621
PMCPMC3934833

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.